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Abstract
Objective: To determine the methods of anesthesia currently being used by pediatric rheumatologists when
performing intra-articular corticosteroid injections (IACI).
Study design: A questionnaire was emailed to all members of the Childhood Arthritis & Rheumatology Research
Alliance, a pediatric rheumatology research network in North America. The questionnaire consisted of 11 questions
ranging from procedure technique, treatments prescribed for topical anesthesia and oral analgesia, and factors that
might affect procedural pain.
Results: Seventy-four of 161 physicians (46%) responded to the questionnaire. On average, each physician injected
33 children (median 25, range 1-160) and 43 joints (median 30, range 1-150) yearly. Local anesthesia was used in
children on average ≥ 8 years (range 2-16 years), with general anesthesia being more frequently used for younger
children. All respondents used local anesthesia. The most commonly used methods of local anesthesia were EMLA®
cream plus subcutaneous lidocaine (58.8%), ethyl chloride spray only (39.7%), EMLA® cream only (33.8%),
subcutaneous lidocaine only (25%), and lidocaine iontophoresis only (11.8%). Buffering of the lidocaine was
routinely done only 7.4% of the time.
Conclusion: Although pediatric rheumatologists in North America perform IACI on a large number of patients
each year, a wide variety of methods are used to deliver local anesthesia with no accepted standard of care. More
studies are needed to determine the optimal method of local anesthesia delivery to minimize pain associated with
IACI.
Introduction
Intra-articular corticosteroid injections (IACI) are one of
the mainstays of treatment for children with chronic
arthritis [1-7]. IACI enables the physician to deliver
localized treatment and may obviate the need for sys-
temic medication or serve as an adjunct to systemic
medications [1,2,4]. Another advantage is the rapidity of
response to the IACI, which usually occurs within a few
days of the injection [4]. IACI is most frequently used
for children with oligoarticular juvenile idiopathic arthri-
tis. If children have only one or two affected joints, it
may be the only treatment used [1,3-5]. One of the dis-
advantages of IACI is the pain associated with the
procedure. In one survey looking at the use of IACI for
treatment of juvenile idiopathic arthritis, 43% of respon-
dents regarded pain of procedure as a disadvantage to
IACI therapy [7]. However, despite the frequent use of
IACI by pediatric rheumatologists, there have been no
studies performed to evaluate the relative efficacy of dif-
ferent methods of anesthesia, and consequently there
seems to be no widely accepted standard of care for the
provision of anesthesia in IACI.
Local anesthetics used for IACI may include EMLA®
cream [6], lidocaine iontophoresis [8] and subcutaneous
lidocaine [4], as well as ethyl chloride spray or ELA-Max®
(4% liposomal lidocaine). EML A ® ,ae u t e c t i cm i x t u r eo f
topical lidocaine 2.5% and prilocaine 2.5%, is a water
emulsion cream base applied to skin under occlusion,
either with a Tegaderm patch [3 M, St. Paul, MN] or plas-
tic wrap 60 minutes prior to the procedure. It has been
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dures in children [9]. Although the only study formally
assessing its role in IACI in children with chronic arthritis
found it to be ineffective [6], it is commonly used by
pediatric rheumatologists for IACI. Subcutaneous injection
of lidocaine 2% solution is commonly used for many pro-
cedures including joint aspiration and injection [4]. The
administration of lidocaine can be painful, but buffering it
with sodium bicarbonate has been shown to make its
injection significantly less painful [10].
Lidocaine iontophoresis is a safe, non-invasive way of
delivering topical lidocaine. Low-level electrical current
drives the lidocaine into the skin [11]. It is being used
prior to IV cannulation [12], venipuncture [13], joint
injections [8] and dermatologic procedures [14] with
good results. The side-effects of iontophoresis include
erythema, tingling and itching at the application site
[11]. Rarely burns have been reported [11]. Iontophor-
esis may not be tolerated by all children due to the dis-
comfort from the electrical current.
Some children, particularly very young children, or
those undergoing injection of multiple joints, are sedated
using such agents as propofol [4,6], midazolam [6,8],
ketamine [4] and nitrous oxide [5]. The relative frequen-
cies of use of different methods of local anesthetic and
sedation by pediatric rheumatologists are unknown.
Methods
Members of the Childhood Arthritis & Rheumatology
Research Alliance (CARRA), a research network of all aca-
demic pediatric rheumatology centers in North America,
received an 11 question self-administered, free response
and multiple choice questionnaire between April and June
2005 either by email or distribution at the annual CARRA
meeting inquiring about anesthesia for subjects receiving
IACI. Questions pertained to procedure technique, medi-
cations prescribed for topical anesthesia, oral analgesia,
the use of sedation, and factors affecting their use. The
responding physician’s beliefs regarding their patients’
experience of pain during the procedure were examined,
as were the important factors affecting the level of proce-
dural pain as per the responding physician.
Results
Seventy-four of 161 physicians (46%) (55 from the USA
and 15 from Canada) responded to the questionnaire.
Respondents reported injecting a mean of 33 children
(median 25, range 1-160) and 43 joints (median 30, range
1-150) yearly. Forty-three percent of physicians reported
that they aspirate the joint to “dryness” prior to injecting
corticosteroids. Local anesthesia was reported to be used
in children with a median age of 8 years (2-16 years).
Although a wide variety of local anesthetic methods were
used (see Table 1), all respondents use local anesthesia
for IACI. Factors affecting the physician’s decision to use
local or general anesthesia are listed in Table 2.
Conscious sedation or general anesthesia was used by
85% of physicians. Sixty percent reported use of more
than 1 sedative. At many institutions, the agent used
was at the discretion of the anesthesiologist. Conscious
sedation or general anesthesia was used for the follow-
ing reasons: patients ≤ 8 years of age, patients needing
multiple joints injected and patients having IACI of
small joints such as in the hand. The most frequently
used agents for conscious sedation are listed in Table 3.
Physicians reported that they believe the majority of
their patients (78%) experience mild or no pain during
IACI, with only 4% of patients experiencing severe pain.
Sixty-seven percent of physicians believe that giving
unbuffered subcutaneous lidocaine may actually increase
procedural pain, but only 7% of physicians buffered the
lidocaine. Other factors cited as potentially contributing to
procedural pain included: patient (57%) and parent (68%)
anxiety regarding the procedure, multiple joint injections
at one time (38%), young patient age (57%), injection of
small joints (10%), severity of the arthritis (7%), difficulty
of aspiration/injection (4%), history of prior joint injection
without the use of anesthesia (3%) and physician confi-
dence and speed (3%). Forty-four percent of physicians
prescribed oral analgesics routinely for use after the IACI.
The type of analgesic used was not assessed.
Table 1 Local anesthesia delivery methods* used by
pediatric rheumatologists for intra-articular corticoster-
oid injections
Method Percent
EMLA†® cream + subcutaneous lidocaine 58.8
Ethyl chloride spray 41.2
EMLA® cream 33.8
Subcutaneous lidocaine
Non-buffered lidocaine 29.4
Routine buffering of lidocaine 7.4
Lidocaine iontophoresis 11.8
* Use of more than one local anesthesia method for IACI was reported by
60% of responding physicians; † Eutectic mixture of topical lidocaine.
Table 2 Factors determining the type and method of
anesthesia use during intra-articular corticosteroid
injections
Factor Percent
Patient age 79.4
Number of joints to be injected 75.0
Parental anxiety 45.6
Patient anxiety 82.4
Joint size 33.8
Availability of insurance 4.4
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Although pediatric rheumatologists in North America
perform IACI on a large number of patients each year, a
wide variety of methods are used to provide anesthesia,
and there is no accepted standard of care regarding the
best methods to be used. Although most patients were
thought to experience no pain or mild pain using var-
ious methods of local anesthesia, it is known that nurses
and physicians often underestimate procedural pain [5].
Many physicians were concerned that unbuffered sub-
cutaneous lidocaine contributed significantly to the pain
of the procedure, but very few attempted to prevent this
pain by buffering the lidocaine. It is not known if physi-
cians are unaware of the benefits of buffering the lido-
caine or if it is impractical in the physician’s office.
It is interesting that less than half of the respondents
aspirated the joint prior to injection, since Weitoft, et al
found that synovial fluid aspiration reduces the risk of
relapse in rheumatoid arthritis patients [15]. There are a
number of reasons that may make it more difficult to
aspirate the joint prior to IACI in the pediatric patient,
such as added discomfort (especially if attempting to
aspirate the joint to dryness) and difficulty holding still
(if local anesthesia is being used). A similar study in
pediatrics would be useful to address the benefit of fluid
aspiration prior to IACI.
Limitations of this study include responder bias and
physician self-reporting. Little is known about the child
or the parent’s perception of pain during IACI using the
different methods of anesthesia, and this study was not
able to address this issue.
Given the variety of methods used by pediatric rheu-
matologists, it is probable that there is a significant var-
iation in the actual amount of procedural pain being
experienced by children with JIA undergoing IACI.
More studies are needed to address this issue and to
determine the optimal methods of providing pain relief
delivery during this commonly used procedure.
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Table 3 Frequency and agents used for sedation during
intra-articular corticosteroid injections
Method Percent
Midazolam (IV) 39.5
Midazolam (oral) 9.0
Propofol 19.0
Fentanyl or vistanyl 19.0
Ketamine 12.0
Gas (sevoflurane, nitrous oxide, isoflurane, halothane) 30.0
Other 16.0
* Use of more than one sedative for IACI was reported by 60% of responding
physicians.
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